A 34-year-old woman presented with sudden breast enlargement that had occurred within 6 months. She also had an accessory breast mass on the left axilla. Clinical impression was phyllodes tumor. Needle biopsy revealed fibroepithelial tumor, a mixture of fibrous stroma and pseudoangiomatous stromal hyperplasia. The final pathologic report was hamartoma associated with focal pseudoangiomatous stromal hyperplasia and macromastia. This is the first reported case of bilateral breast hamartoma with hamartoma in ectopic breast tissue. The masses on the right and left breasts weighed 1,980 g and 1,233 g, respectively, while the mass on the left axilla weighed 36 g.
INTRODUCTION
Breast hamartoma is an uncommon benign disease of the breast, accounting for 4.8% of all benign breast masses [1] . Hamartomas comprise varying proportions of fat, fibrous, and adenomatous elements, which result in different radiologic and pathologic findings. Thus, hamartomas are easily confused with other well-circumscribed, benign breast diseases such as phyllodes tumors and fibroadenomas.
Moreover, breast hamartoma is usually found unilaterally, ranging in size from 0.9 to 6.9 cm [1] .
Herein, we report an unusual case of huge bilateral breast hamartoma with hamartoma in axillary ectopic breast tissue.
CASE REPORT
A 34-year-old woman visited Breast Center of Inje University Busan Paik Hospital for the evaluation of hard bilateral breast masses; the right and left masses were 25 cm and 18 cm in size, respectively ( Figure   1A ). She had no medical history, and her family did not have any breast-related medical history. The patient was not married and had no children. The patient's previous breast size was A cup, but her breasts had gradually enlarged to the aforementioned size in only 6 months. She also had a mass on her left axilla.
The masses were a conglomeration of multiple well-defined heterogeneously hypoechoic masses, occupying almost the entirety of both breasts on ultrasonography. Some of the masses had internal slit-like The results of the hormone essays were as follows: estradiol, 290 pg/ mL; follicle-stimulating hormone, 2.02 mlU/mL; prolactin, 9.16 ng/ mL; and progesterone, 13.02 ng/mL. All these results were within normal ranges. Twelve months after the surgery, the patient has not experienced any complications or tumor recurrence.
DISCUSSION
We performed surgery for an unusual case of macromastia confirmed as bilateral breast hamartoma, with hamartoma in axillary ectopic breast tissue.
The definition of macromastia or gigantomastia varies, but the most common definition is breast enlargement that requires breast reduction surgery to remove >1,800 g of tissue on each side [2] . Differential diagnosis for breast hypertrophy includes virginal hypertrophy, gravid hypertrophy, fibroepithelial tumors, traumatic hypertrophy, and pseudohypertrophy due to obesity, in addition to endocrine abnormalities [3] . Because hamartoma is an excess of normal tissue, our patient's cause of breast hypertrophy is thought to be due to hamartoma itself. The reason the patient's breasts had markedly enlarged from A cup-sized breasts to gigantomastia within only 6 months is still unclear. However, because her estrogen and progesterone levels were within normal ranges, and the immunohistochemistry stain for EGFR was focally positive, it could be speculated that her breast parenchyma had become hypersensitive to estrogen, progesterone or certain growth factors.
Breast hamartoma is an uncommon benign breast disease, and its
pathogenesis is yet to be elucidated. Most breast hamartomas are found unilaterally; very few cases of bilateral breast hamartomas have been reported, and, to date, no case of bilateral breast hamartoma with hamartoma in ectopic breast tissue has been reported [4] . Sizes of hamartomas vary from as small as a few centimeters to 25 cm. The conglomeration of radiologic and pathologic findings is important in the diagnosis of hamartomas. Depending on the varying proportions of fat and fibroglandular tissue, radiologic studies show inconsistent traits, making diagnosis difficult. It is widely known that the diagnostic value of needle biopsy in breast hamartoma is very limited, often misdiagnosing as fibroadenoma or other benign diseases [5] . Therefore, complete excision of hamartoma is imperative in the diagnosis.
Radiologically, hamartomas have a mammographic appearance typical of lucent lesions containing fat, varying proportions of radiodense fibrous and adenomatous elements, sharp margins, and in some cases, a thin capsule [6] . The role of ultrasonography in the diagnosis of hamartomas is limited because hamartomas may have a wide range of ultrasonographic appearances. In a study by Chao et al. [7] , breast hamartomas are well-circumscribed, solid, oval tumors without intratumoral microcalcification. The internal echo texture of most hamartomas is either hyperechoic or of mixed echogenicity.
They are often described as a "slice of salami" [8] . Characteristic MRI findings of hamartomas include heterogeneous intensities on conventional T1-and T2-weighted MRI, which correlate with their fatty, fibroglandular contents and thin capsule [5] .
Pathologically, a definite diagnostic criterion for hamartoma is still lacking; however, a hamartoma consists of a mixture of benign epithelial elements, fibrous tissue, and fat. Normal compressed tissue along the periphery of the mass is another significant pathologic finding [7] .
Our case was diagnosed as hamartoma with PASH. PASH was first described by Vuitch et al. [9] in 1986, indicating a benign breast dis- 
